IP Library › Granted Patent US 7,034,028
Granted Patent B2
US 7,034,028 · App. 10/362,784 · Granted Apr 25, 2006

Treatment of inflammatory disorders

Assignee: Arakis Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,034,028
App. No.
10/362,784
Granted
Apr 25, 2006
Kind
B2
Abstract

A method of treating an inflammatory disease or an autoimmune disease in a subject, comprises the administration of mefloquine.

Claims (1)

1. A method for inhibiting IL-2 and/or IL-8 production in a patient in need thereof, wherein said method comprises administering an effective amount of (+)-erythro-mefloquine to said patient, wherein said patient is diagnosed with rheumatoid arthritis or osteoarthritis.

Assignments (2)
CHANGE OF NAME Recorded Jan 31, 2007
From: ARAKIS LIMITED
To: SOSEI R&D LTD.
Reel/Frame 018826/0339 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2003
From: SKEAD, BENJAMIN MARK; BANNISTER, ROBIN MARK; ROTHAUL, ALAN
To: ARAKIS LTD.
Reel/Frame 014435/0421 →
Priority Claims (1)
GB 0021776.0 · Sep 5, 2000 · national
Continuity (1)
Related Publication 20040029916A1 · Feb 12, 2004